Inhibrx Biosciences, Inc. <INBX.O>: H.C. Wainwright Initiates Coverage With Buy Rating and Target Price $245
INBX•Related News
Insmed says Japan health ministry approves BRINSUPRI for non-cystic fibrosis bronchiectasis
INSM•
IsoEnergy signs exploration agreement with Kineepik Métis Local for Saskatchewan uranium work
ISOU•
Ups Invests More Than $2 Billion To Give Customers Even Faster Service, More Control And More Resilient Global Supply Chains
UPS•
NAPCO FY26 Q4 net income rises 52.7% to USD 17.8 million; revenue increases 10% to USD 55.8 million
NSSC•
Promino Nutritional Sciences wins Kroger pharmacy test order for Rejuvenate in 662 stores
KR•